247 related articles for article (PubMed ID: 27741441)
1. Chronic hepatitis C virus infection and pathogenesis of hepatocellular carcinoma.
Bandiera S; Billie Bian C; Hoshida Y; Baumert TF; Zeisel MB
Curr Opin Virol; 2016 Oct; 20():99-105. PubMed ID: 27741441
[TBL] [Abstract][Full Text] [Related]
2. Risk of cirrhosis-related complications in patients with advanced fibrosis following hepatitis C virus eradication.
van der Meer AJ; Feld JJ; Hofer H; Almasio PL; Calvaruso V; Fernández-Rodríguez CM; Aleman S; Ganne-Carrié N; D'Ambrosio R; Pol S; Trapero-Marugan M; Maan R; Moreno-Otero R; Mallet V; Hultcrantz R; Weiland O; Rutter K; Di Marco V; Alonso S; Bruno S; Colombo M; de Knegt RJ; Veldt BJ; Hansen BE; Janssen HLA
J Hepatol; 2017 Mar; 66(3):485-493. PubMed ID: 27780714
[TBL] [Abstract][Full Text] [Related]
3. The dynamic effect of direct-acting antiviral treatments on the risk of hepatocellular carcinoma in patients with cirrhosis and chronic hepatitis C.
Lusivika-Nzinga C; Fontaine H; Dorival C; Simony M; Pol S; Carrat F;
J Viral Hepat; 2019 Dec; 26(12):1489-1492. PubMed ID: 31386252
[TBL] [Abstract][Full Text] [Related]
4. Long-term effect of sustained virological response on hepatocellular carcinoma in patients with hepatitis C in Canada.
Janjua NZ; Chong M; Kuo M; Woods R; Wong J; Yoshida EM; Sherman M; Butt ZA; Samji H; Cook D; Yu A; Alvarez M; Tyndall M; Krajden M
J Hepatol; 2017 Mar; 66(3):504-513. PubMed ID: 27818234
[TBL] [Abstract][Full Text] [Related]
5. Cost Effectiveness of Hepatocellular Carcinoma Surveillance After a Sustained Virologic Response to Therapy in Patients With Hepatitis C Virus Infection and Advanced Fibrosis.
Farhang Zangneh H; Wong WWL; Sander B; Bell CM; Mumtaz K; Kowgier M; van der Meer AJ; Cleary SP; Janssen HLA; Chan KKW; Feld JJ
Clin Gastroenterol Hepatol; 2019 Aug; 17(9):1840-1849.e16. PubMed ID: 30580095
[TBL] [Abstract][Full Text] [Related]
6. The pathogenesis of hepatocellular carcinoma is multifactorial event. Novel immunological treatment in prospect.
Marotta F; Vangieri B; Cecere A; Gattoni A
Clin Ter; 2004 May; 155(5):187-99. PubMed ID: 15344567
[TBL] [Abstract][Full Text] [Related]
7. Action and function of Wnt/β-catenin signaling in the progression from chronic hepatitis C to hepatocellular carcinoma.
Wang W; Pan Q; Fuhler GM; Smits R; Peppelenbosch MP
J Gastroenterol; 2017 Apr; 52(4):419-431. PubMed ID: 28035485
[TBL] [Abstract][Full Text] [Related]
8. Development and surveillance of hepatocellular carcinoma in patients with sustained virologic response after antiviral therapy for chronic hepatitis C.
Na SK; Song BC
Clin Mol Hepatol; 2019 Sep; 25(3):234-244. PubMed ID: 30661334
[TBL] [Abstract][Full Text] [Related]
9. Molecular Mechanisms of Hepatocarcinogenesis Following Sustained Virological Response in Patients with Chronic Hepatitis C Virus Infection.
Hayes CN; Zhang P; Zhang Y; Chayama K
Viruses; 2018 Sep; 10(10):. PubMed ID: 30274202
[TBL] [Abstract][Full Text] [Related]
10. Oncogenic viruses and hepatocellular carcinoma.
Ben Ari Z; Weitzman E; Safran M
Clin Liver Dis; 2015 May; 19(2):341-60. PubMed ID: 25921667
[TBL] [Abstract][Full Text] [Related]
11. Molecular Mechanisms Driving Progression of Liver Cirrhosis towards Hepatocellular Carcinoma in Chronic Hepatitis B and C Infections: A Review.
Kanda T; Goto T; Hirotsu Y; Moriyama M; Omata M
Int J Mol Sci; 2019 Mar; 20(6):. PubMed ID: 30889843
[TBL] [Abstract][Full Text] [Related]
12. Hepatitis C virus and hepatocellular carcinoma.
Colombo M
Semin Liver Dis; 1999; 19(3):263-9. PubMed ID: 10518306
[TBL] [Abstract][Full Text] [Related]
13. Hepatocellular carcinoma in patients with chronic hepatitis C virus infection without cirrhosis.
Nash KL; Woodall T; Brown AS; Davies SE; Alexander GJ
World J Gastroenterol; 2010 Aug; 16(32):4061-5. PubMed ID: 20731020
[TBL] [Abstract][Full Text] [Related]
14. Differences in surgical outcomes between hepatitis B- and hepatitis C-related hepatocellular carcinoma: a retrospective analysis of a single North American center.
Franssen B; Alshebeeb K; Tabrizian P; Marti J; Pierobon ES; Lubezky N; Roayaie S; Florman S; Schwartz ME
Ann Surg; 2014 Oct; 260(4):650-6; discussion 656-8. PubMed ID: 25203882
[TBL] [Abstract][Full Text] [Related]
15. Hepatocellular carcinoma risk after viral response in hepatitis C virus-advanced fibrosis: Who to screen and for how long?
Ahumada A; Rayón L; Usón C; Bañares R; Alonso Lopez S
World J Gastroenterol; 2021 Oct; 27(40):6737-6749. PubMed ID: 34790004
[TBL] [Abstract][Full Text] [Related]
16. Early occurrence and recurrence of hepatocellular carcinoma in HCV-related cirrhosis treated with direct-acting antivirals.
Conti F; Buonfiglioli F; Scuteri A; Crespi C; Bolondi L; Caraceni P; Foschi FG; Lenzi M; Mazzella G; Verucchi G; Andreone P; Brillanti S
J Hepatol; 2016 Oct; 65(4):727-733. PubMed ID: 27349488
[TBL] [Abstract][Full Text] [Related]
17. Oncologic Implications of Chronic Hepatitis C Virus Infection.
Hwang JP; LoConte NK; Rice JP; Foxhall LE; Sturgis EM; Merrill JK; Torres HA; Bailey HH
J Oncol Pract; 2019 Dec; 15(12):629-637. PubMed ID: 31825756
[TBL] [Abstract][Full Text] [Related]
18. Newly diagnosed hepatocellular carcinoma in patients with advanced hepatitis C treated with DAAs: A prospective population study.
Romano A; Angeli P; Piovesan S; Noventa F; Anastassopoulos G; Chemello L; Cavalletto L; Gambato M; Russo FP; Burra P; Vincenzi V; Scotton PG; Panese S; Tempesta D; Bertin T; Carrara M; Carlotto A; Capra F; Carolo G; Scroccaro G; Alberti A
J Hepatol; 2018 Aug; 69(2):345-352. PubMed ID: 29551707
[TBL] [Abstract][Full Text] [Related]
19. Serum sphingolipids predict de novo hepatocellular carcinoma in hepatitis C cirrhotic patients with sustained virologic response.
Mücke VT; Thomas D; Mücke MM; Waidmann O; Zeuzem S; Sarrazin C; Pfeilschifter J; Vermehren J; Finkelmeier F; Grammatikos G
Liver Int; 2019 Nov; 39(11):2174-2183. PubMed ID: 31207039
[TBL] [Abstract][Full Text] [Related]
20. Hepatitis C virus-induced hepatocellular carcinoma: a narrative review.
Ružić M; Pellicano R; Fabri M; Luzza F; Boccuto L; Brkić S; Abenavoli L
Panminerva Med; 2018 Dec; 60(4):185-191. PubMed ID: 29856183
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]